|
1.
Alka Bali., Yogita Bansal., M. Sugumaran., Jatinder Singh Saggu, P. Balakumar., Gurpreet Kaur., Gulshan Bansa.l, Ajay Sharma., Manjeet Singh.: Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists. Bioorg.Med. Chem. Lett., 15,3962-3965.( 2005)
2.
Hiroshi U., Susumu K., Katsuyuki Y., Jun-ichi H., Mikio H., Itsuo U., Kazuo A., Yasunori H. and Hidetsura C.: Structure–activity Relationships of Potent and Selective Factor Xa Inhibitors, Benzimidazole Derivatives with the Side Chain Oriented to the Prime Site of Factor Xa, Bioorg. & Med. Chem. Lett., 14, 4281–4286 (2004)
3.
Farukh Arjmand., Bhawana Mohani., Shamim Ahmad.: Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu(II)complex,Eur.J.Med.Chem.,40,1103-1110
(2005)
4.
E. I. Elnima., M. U. Zubair., A. A. Al-Badr.: Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives,Agents Chemother.29-32(1981)
5.
Jun Cheng., Jiangtao Xie., Xianjin Luo.: Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives, Bioorg. & Med. Chem. Lett.,15,267-269(2005)
6.
R. Paramashivappa., P. Phani Kumar., P.V. Subba Rao., A. Srinivasa Rao.: Design, synthesis and biological evaluation of benzimidazole/
benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors, Bioorg. & Med. Chem. Lett.,13,657-660(2003)
7.
Christian Beaulieu., Zhaoyin Wang., Danielle Denis., Gillian Greig., Sonia Lamontagne., Gary O''Neill., Deborah Slipetz., Jennifer Wang.: Benzimidazoles as new potent and selective DP antagonists for the treatment of allergic rhinitis, J.Med.Chem.,14,3195-3199(2004)
8.
Mark L. R., Shirley C. L., Anjana S., Kenneth K. T., and Jagadish C. S.: Novel 2-(Substituted phenyl)benzimidazole Derivatives with Potent Activity Against IgE, Cytokines, and CD23 for the Treatment of Allergy and Asthma, J. Med. Chem., 47, 6451–6454 (2004)
9.
Kristina S., Marijeta K., Katja E., Ivan S., Magdalena G., Kresˇimir P., and Grace K.-Z.: Synthesis, Antiviral and Antitumor Activity of 2-Substituted-5-amidino-benzimidazoles, Bioorg. & Med. Chem., 15, 4419–4426 (2007)
10.
Christian Beaulieu., Zhaoyin Wang., Danielle Denis., Gillian Greig., Sonia Lamontagne., Gary O''Neill., Deborah Slipetz., Jennifer Wang.: Benzimidazoles as new potent and selective DP antagonists for the treatment of allergic rhinitis, Bioorg. & Med. Chem. Lett.,21,3195-3199
(2004)
11.
Tomohiro Y., Shozo Y., Yasundo Y., and Hideo T.: New Procedure for the Synthesis of 2-Alkylbenzimidazoles, Synthetic Communications, 39, 2982 –2988 (2009)
12.
Kiumars B., Mohammad M. K., and Akbar N.: Synthesis of 1,2-Disubstituted Benzimidazoles, 2-Substituted Benzimidazoles and 2-Substituted Benzothiazoles in SDS Micelles, Green Chem., 12, 1237–1241 (2010)
13.
Kiumars B., Mohammad M. K., Iman K.: A Simple and Efficient One-Pot Synthesis of 2-Substituted Benzimidazoles, Synthesis, 417-427 (2007)
14.
Pauline J. S., Maud U., Jeffery B. P., Zoltan G. H., David A. S., and Cynthia K. S.: Synthesis of (Aryloxy)alkylamines. 1. Novel Antisecretory Agents with H+K+-ATPase Inhibitory Activity, J. Med. Chem., 31, 1778-1785 (1988)
15.
Hakan G., Canan K., David W. B., Sulhiye Y., and Nurten A.: Synthesis of Some New 2-Substituted-phenyl-1H-benzimidazole-5-carbonitriles and Their Potent Activity Against Candida Species, Bioorg. & Med. Chem., 10, 2589–2596 (2002)
16.
Faller A., Schuenke M., Thieme, The Human Body, 279-281 (2004)
17.
Baumgartner H. P., Muggli R., Tschopp T. B. and Turitto V. T.: Platelet Adhension, Release and Aggregation in Flowing Blood : Effects of Surface Properties and Platelet Function., Thromb. haemost., 35, 124-138 (1976)
18.
Stemerman M. B., Baumgartner H.R. and Spaet T.H.: The Subendothelial Microfibril and Adhesion. Lab. Invest., 24, 176-186 (1972)
19.
Malmsten C., Hamberg M., Svensson J., and Samuelsson B.: Physiological Role of and Endoperoxide in Human Platelets : Hemostatic Defect Due to Cyclooxygenase Deficiency., Proc. Natl. Acad. Sci., 72, 1446-1448 (1975)
20.
Billes T., Smith J. B., and Silver M. J.: Metabolism of 14C – Arachidonic acid by Human Platelets., Biochem. Biophys. Acta, 241, 303-314 (1976)
21.
Shepherd J. T. and Katusic Z. S., Endothelium Derived Vasoactive Factors: Endothelium-dependent Relaxation, Hypertension, 18 (Suppl.III), 76-85 (1991)
22.
Huang E. M. and Detwiler W. D.: Stimulus-response Coupling Mechanism, Orlande FL, Academic Press, l-68 (1986)
23.
Waldman S. A., and Murad F.: Cyclic GMP Synthesis and Function, Pharmacol Rev., 39, 163-196 (1987)
24.
Yao-Zu X., Li-Yuan K., Xiu-Mei G., Hong-Cai S., Jun-Hua Z., Bo-Li Z.: Strategies for Antiplatelet Targets and Agents, Thrombosis Research, 123, 35-49 (2008)
25.
Coller B. S.: Antiplatelet Agents in the Prevention and Therapy of Thrombosis., Annu. Rev. Med., 43, 171-180 (1992)
26.
Fontanal P., J.-L. Reny2: New Antiplatelet Strategies in Therothrombosis and Their Indications, Eur J Vasc Endovasc Surg, 34, 10-17 (2007)
27.
Telly A. M., Deepak L. B.: Clinical Aspects of Platelet Inhibitors and Thrombus Formation, Circ. Res., 100, 1261-1275 (2007)
28.
Shaun P. J. & Simone M. S.: Antiplatelet therapy: in search of the ''magic bullet''., Nat. Rev. Drug. Discov., 775-789 (2003)
29.
Philip W. M., George J. B., Joseph P. M., and Douglas M. T.: Anticoagulant, Thrombolytic, and Antiplatelet Drugs. in Goodman and Gilman’s (eds): The Pharmacological Basis of Therapeutic. New York : Pergamon Press, Chap. 55, 1311-1331 (1990)
30.
Abhay K. P., MD, FACC, FESC, Kainal K. S., MD, FACC :Newer Orally Active Antiplatelet Agents : Do They Have An Edge Over Aspirin, Heart Views , 1, 258-26 (2000)
|